Keyword:
Clinical Trials, Phase I as Topic
Details:
Experience with design, conduct and power calculations for 3+3 trials, Up and down designs, continual reassessment method trial designs (frequentist and Bayesian), time to event continual reassessment method trial designs, subgroup specific dose finding in phase I trials.
|